Anti-citrullinated peptide antibody: Death of the rheumatoid factor?

Medical Journal of Australia

Volumn 190, Issue 12, 2009, Pages 693-695

  Chatfield, Simon M ^a   Wicks, Ian P ^a,b   Sturgess, Allan D ^c   Roberts, Lynden J ^d  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

^d TOWNSVILLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ANTIBODY DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISABILITY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEALTH CARE COST; HUMAN; JOINT INJURY; RHEUMATOID ARTHRITIS; BLOOD; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 68349116219     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02640.x     Document Type: Article

References (11)

1. Harris ED Jr, editor. Kelley's textbook of rheumatology. 7th ed. Philadelphia: Elsevier Science, 2005.
2. Roberts LJ, Cleland LG, Thomas R, Proudman SM. Early combination disease modifying antirheumatic drug treatment for rheumatoid arthritis. Med J Aust 2006; 184: 122-125. (Pubitemid 43256913)
3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
4. Litwin SD, Singer JM. Studies of the incidence and significance of anti-gamma globulin factors in the aging. Arthritis Rheum 1965; 8: 538-550.
5. Schellekens GA, de Jong BA, van den Hoogen FH, et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-281.
6. Girbal-Neuhauser E, Durieux JJ, Arnaud M, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999; 162: 585-594. (Pubitemid 29018970)
7. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006; 65: 845-851.
8. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007; 146: 797-808. (Pubitemid 351650500)
9. McGee S. Simplifying likelihood ratios. J Gen Intern Med 2002; 17: 646-649.
10. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005; 365: 1500-1505.
11. Nell VP, Machold KP, Stamm TA, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1731-1736. (Pubitemid 41667147)